PARLIAMENTARY WRITTEN QUESTION
(14 November 2024)

Question Asked

What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.

Asked by:
Ben Obese-Jecty (Conservative)

Answer

The Medicines and Healthcare products Regulatory Agency (MHRA) attended a ministerial roundtable on accelerating the adoption of alternatives to using animals for drug development earlier this year.


Answered by:
Feryal Clark (Labour)
20 November 2024

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.